TIDMSUMM
Summit Corporation plc ('
Summit' or 'the Company') NOTICE OF ANNUAL GENERAL MEETING Oxford, UK, 7 May 2013 -
Summit (AIM: SUMM), a drug discovery and development company advancing therapies to treat Duchenne Muscular Dystrophy and C. difficile ...
[Published ADVFN UK - May 07 2013]